Lannett Stock Forecast, Price & News

Lannett (NYSE:LCI) Frequently Asked Questions

Is Lannett a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lannett in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Lannett stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LCI, but not buy additional shares or sell existing shares.
View analyst ratings for Lannett or view top-rated stocks.

How has Lannett's stock price been impacted by Coronavirus?

Lannett's stock was trading at $7.74 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LCI shares have decreased by 79.3% and is now trading at $1.60.
View which stocks have been most impacted by COVID-19.

When is Lannett's next earnings date?

Lannett is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for Lannett.

How were Lannett's earnings last quarter?

Lannett Company, Inc. (NYSE:LCI) issued its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.27) EPS for the quarter, missing analysts' consensus estimates of ($0.25) by $0.02. The business earned $101.53 million during the quarter, compared to the consensus estimate of $98.62 million. Lannett had a negative trailing twelve-month return on equity of 31.06% and a negative net margin of 83.58%. During the same period in the previous year, the business posted $0.06 earnings per share.
View Lannett's earnings history.

What guidance has Lannett issued on next quarter's earnings?

Lannett issued an update on its FY 2022 earnings guidance on Wednesday, November, 17th. The company provided EPS guidance of for the period. The company issued revenue guidance of $370 million-$400 million, compared to the consensus revenue estimate of $430.15 million.

What price target have analysts set for LCI?

1 Wall Street analysts have issued 1 year price objectives for Lannett's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Lannett's stock price to reach $6.00 in the next twelve months. This suggests a possible upside of 275.0% from the stock's current price.
View analysts' price targets for Lannett or view top-rated stocks among Wall Street analysts.

Who are Lannett's key executives?

Lannett's management team includes the following people:

• Timothy C. Crew, Chief Executive Officer & Director
• John M. Abt, Chief Operations & Quality Officer, Vice President
• John Kozlowski, CFO, Principal Accounting officer & VP-Finance
• Robert Ehlinger, Chief Information Officer & VP-Logistics
• Maureen M. Cavanaugh, Chief Commercial Operations Officer & Senior VP

What is Timothy Crew's approval rating as Lannett's CEO?

9 employees have rated Lannett CEO Timothy Crew on Glassdoor.com. Timothy Crew has an approval rating of 28% among Lannett's employees. This puts Timothy Crew in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Lannett's key competitors?

Some companies that are related to Lannett include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Eli Lilly and (LLY), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT) and Supernus Pharmaceuticals (SUPN).
View all of LCI's competitors.

What other stocks do shareholders of Lannett own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lannett investors own include (CELG), Akorn (AKRX), Skechers U.S.A. (SKX), Integrated Device Technology (IDTI), Bank of America (BAC), Alibaba Group (BABA), Gilead Sciences (GILD), Micron Technology (MU), Rite Aid (RAD) and NVIDIA (NVDA).

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

Who are Lannett's major shareholders?

Lannett's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include HealthInvest Partners AB (4.62%). Company insiders that own Lannett stock include David A Drabik, Jeffrey Farber, John Kozlowski, Patrick G Lepore and Timothy C Crew.
View institutional ownership trends for Lannett.

Which institutional investors are buying Lannett stock?

LCI stock was purchased by a variety of institutional investors in the last quarter, including HealthInvest Partners AB. Company insiders that have bought Lannett stock in the last two years include Jeffrey Farber, John Kozlowski, Patrick G Lepore, and Timothy C Crew.
View insider buying and selling activity for Lannett or or view top insider-buying stocks.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $1.60.

How much money does Lannett make?

Lannett has a market capitalization of $69.28 million and generates $478.78 million in revenue each year. The company earns $-363.48 million in net income (profit) each year or ($9.60) on an earnings per share basis.

How many employees does Lannett have?

Lannett employs 954 workers across the globe.

What is Lannett's official website?

The official website for Lannett is www.lannett.com.

Where are Lannett's headquarters?

Lannett is headquartered at 9000 STATE ROAD, PHILADELPHIA PA, 19136.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at (215) 333-9000 or via fax at 215-333-9004.